COPD study seeks to personalize steroid treatment using blood markers

NCT ID NCT06334575

First seen Mar 10, 2026 · Last updated May 10, 2026 · Updated 8 times

Summary

This study aims to identify molecular changes in COPD patients that predict how they respond to inhaled corticosteroids (ICS). Researchers will compare patients with different blood eosinophil levels, a type of white blood cell, to see who benefits most from adding ICS to their usual bronchodilator therapy. The study enrolls 135 former smokers with moderate-to-severe COPD who are not currently on ICS. Results may help doctors tailor COPD treatments more precisely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Academisch Ziekenhuis Groningen

    RECRUITING

    Groningen, Netherlands

    Contact

  • Clínic Barcelona

    RECRUITING

    Barcelona, 08036, Spain

    Contact

  • Imperial College London

    NOT_YET_RECRUITING

    London, United Kingdom

    Contact

  • Philips University of Marburg

    RECRUITING

    Marburg, Germany

    Contact

  • Son Espases

    RECRUITING

    Palma de Mallorca, 07120, Spain

    Contact

  • University of Leicester

    NOT_YET_RECRUITING

    Leicester, United Kingdom

    Contact

Conditions

Explore the condition pages connected to this study.